Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Spot Gold extended gains from a day ago on Friday and looked set to register a weekly gain after two major central banks took no action on interest rates despite rising inflationary pressures, which added to the appeal of the precious metal.

An environment of low interest rates tends to keep the opportunity cost of holding non-yielding assets such as Gold low.

Earlier this week the Federal Reserve said that it would start scaling back its monthly bond purchases and it planned to end the program in 2022. However, the central bank once again confirmed its view that high inflation would probably be transitory and would not require a hasty interest rate increase.

One day after the Federal Reserve’s policy decision, which caused a retreat in 10-year US bond yields from recent highs, the Bank of England also kept borrowing costs intact.

“A lot of investor interest is still mainly in equity markets, and until gold breaks above $1,835, it might not have enough momentum to attract strong interest,” Nicholas Frappell, a global general manager at ABC Bullion, was quoted as saying by Reuters.

As of 10:20 GMT on Friday Spot Gold was edging up 0.14% to trade at $1,794.22 per troy ounce, after earlier touching an intraday high of $1,800.18 per troy ounce. The latter has been the commodity’s strongest price level since October 29th ($1,801.26).

The commodity looked set to register its fourth gain in six weeks, while being up 0.61%. The precious metal appreciated as much as 1.50% in October.

Meanwhile, Gold futures for delivery in December were edging up 0.11% on the day to trade at $1,795.55 per troy ounce, while Silver futures for delivery in December were up 0.09% to trade at $23.933 per troy ounce.

The US Dollar Index, which reflects the relative strength of the greenback against a basket of six other major currencies, was edging up 0.13% to 94.455 on Friday. Yesterday the DXY went up as high as 94.473, which has been its strongest level since October 13th (94.531).

In terms of macroeconomic data, today market players will be paying attention to the October report on US Non-Farm Payrolls, Unemployment Rate and Average Hourly Earnings due out at 12:30 GMT. Employers in all sectors of US economy, except the farming industry, probably added 450,000 new jobs last month, according to a consensus of analyst estimates.

Near-term investor interest rate expectations were without change. According to CME’s FedWatch Tool, as of November 5th, investors saw a 100.0% chance of the Federal Reserve keeping borrowing costs at the current 0%-0.25% level at its policy meeting on December 14th-15th, or unchanged compared to November 4th.

Daily Pivot Levels (traditional method of calculation)

Central Pivot – $1,786.79
R1 – $1,803.94
R2 – $1,816.10
R3 – $1,833.24
R4 – $1,850.39

S1 – $1,774.63
S2 – $1,757.49
S3 – $1,745.33
S4 – $1,733.17

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • EUR/USD close to five-week highsEUR/USD close to five-week highs On Monday the euro traded in proximity to five-week highs against the US dollar, as investors focus was upon upcoming US pending home sales and the statements on monetary policy by the European Central Bank and the Federal Reserve.EUR/USD […]
  • Silver Trades Near $80 as Fed Decision Draws FocusSilver Trades Near $80 as Fed Decision Draws Focus Key Moments XAG/USD trades around $79.90 in early European dealings on Wednesday, supported by safe-haven demand. Technical signals point to a mildly bearish near-term bias, with RSI below 50 and price back inside the Bollinger […]
  • AbbVie Inc.’s share price down, to acquire Shire Plc for $54.8 billion, seeking lower tax rate in the U.K.AbbVie Inc.’s share price down, to acquire Shire Plc for $54.8 billion, seeking lower tax rate in the U.K. AbbVie Inc. announced that it reached an agreement over the acquisition of Shire Plc in a cash-and-stock deal valued at about 32 billion pounds (54.8 billion dollars). This is how AbbVie became the latest U.S.-based health-care company that […]
  • Spot Gold eyes 2nd weekly gain on Fed easing betsSpot Gold eyes 2nd weekly gain on Fed easing bets Spot Gold continued holding in proximity to a 2-month high of $4,374.65/oz. and was on course for its second consecutive weekly advance, as softer-than-expected US inflation data reinforced expectations of further policy easing by the Federal […]
  • Swiss Franc Holds Ground as SNB Rate Hike Odds FallSwiss Franc Holds Ground as SNB Rate Hike Odds Fall Key Moments USD/CHF traded around 0.7890 during Friday's Asian session, marking a second straight day of subdued price action. May Swiss inflation stayed at 0.6% year-on-year, below the 0.8% consensus, dampening expectations […]
  • Crude reserves mismatch forecasts and gainCrude reserves mismatch forecasts and gain According to the U.S. Energy Information Administration, crude oil reserves rose against expectations during the week ending June 7. Crude Oil Inventories rose by 2.5 million barrels to 393.8 million, which is above the average range for this […]